Related Experiment Video
Updated: May 23, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Prevention of bisphosphonates-induced osteonecrosis
Anna Baraldi1, Vittorio Fusco, Alessandro Bellora
1MD Hematology Division, Azienda Ospedaliera "SS Antonio e Biagio e C. Arrigo", Alessandria, Italy.
Abstract:
The osteonecrosis of the jaw is a new emergent disease, secondary to prolonged use of bisphosphonates. Bisphosphonates are a class of drug used in prevention and cure of bone diseases such as malignancy or bone metabolic diseases. In this article, we have tried to summarize, for patients taking IV or oral bisphosphonates-therapy, the most important informations on the pathogenesis and the risk factors in osteonecrosis of the jaw with particular attention about the preventive policies.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Osteoclasts in Bone Remodeling
Urinary Tract Calculi III: Medical Management
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists